Cimetidine-phenytoin interaction: Effect on serum phenytoin concentration and antipyrine test

[1]  V. Aboyans,et al.  [Drug interactions]. , 2015, Journal of the Dental School, National University of Iran.

[2]  E. Reynolds.  Antiepileptic Therapy: Advances in Drug Monitoring , 1980 .

[3]  F. House,et al.  Effect of cimetidine on the absorption of orally administered tetracycline. , 1980, British journal of clinical pharmacology.

[4]  D. G. Fraser,et al.  Displacement of phenytoin from plasma binding sites by salicylate , 1980, Clinical pharmacology and therapeutics.

[5]  E. Vesell.  The antipyrine test in clinical pharmacology: Conceptions and misconceptions , 1979, Clinical pharmacology and therapeutics.

[6]  A. Breckenridge,et al.  CIMETIDINE: INTERACTION WITH ORAL ANTICOAGULANTS IN MAN , 1979, The Lancet.

[7]  P. Neuvonen,et al.  Antipyretic analgesics in patients on antiepileptic drug therapy , 1979, European Journal of Clinical Pharmacology.

[8]  O. Pelkonen,et al.  Cimetidine inhibits microsomal drug metabolism in the rat. , 1979, European journal of pharmacology.

[9]  M. K. Brenner,et al.  Cimetidine: Does Neurotoxicity Occur? Report of Three Cases , 1979, Journal of the Royal Society of Medicine.

[10]  W. Bell,et al.  Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. , 1979, Annals of internal medicine.

[11]  P. Neuvonen.  Bioavailability of Phenytoin: Clinical Pharmacokinetic and Therapeutic Implications , 1979, Clinical pharmacokinetics.

[12]  F. Cerra,et al.  PHARMACOKINETIC AND CLINICAL STUDIES IN PATIENTS WITH CIMETIDINE-ASSOCIATED MENTAL CONFUSION , 1979, The Lancet.

[13]  A. Flind.  CIMETIDINE AND ORAL ANTICOAGULANTS , 1978, The Lancet.

[14]  A. Flind.  Cimetidine and oral anticoagulants. , 1978, British medical journal.

[15]  J. Freston.  CIMETIDINE IN THE TREATMENT OF GASTRIC ULCER Review and commentary , 1978 .

[16]  D. Winship.  Cimetidine in the treatment of duodenal ulcer:Review and commentary , 1978 .

[17]  W. C. Randolph,et al.  High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine. , 1977, Journal of pharmaceutical sciences.

[18]  D. Hetzel,et al.  CIMETIDINE IN THE TREATMENT OF DUODENAL ULCER , 1977, The Medical journal of Australia.

[19]  P. Neuvonen,et al.  Factors affecting the bioavailability of phenytoin. , 1977, International journal of clinical pharmacology and biopharmacy.

[20]  M. Ehrnebo,et al.  Pentazocine binding to blood cells and plasma proteins , 1974, Clinical pharmacology and therapeutics.

[21]  Christie Ad.  Letter: Fetal cephalometry. , 1974 .

[22]  L. Prescott,et al.  Rapid gas‐liquid chromatographic estimation of antipyrine in plasma , 1973, The Journal of pharmacy and pharmacology.

[23]  F. Sjöqvist,et al.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method. , 1972, Scandinavian journal of clinical and laboratory investigation.

[24]  A. Rane,et al.  Plasma protein binding of diphenylhydantoin in man; Interaction with other drugs and the effect of temperature and plasma dilution , 1970, Clinical pharmacology and therapeutics.

[25]  D. B. Duncan.  MULTIPLE RANGE AND MULTIPLE F TESTS , 1955 .

[26]  E. Mühlbachová.  Drug interactions with cimetidine , 1983, Casopis lekaru ceskych.

[27]  A. Somogyi,et al.  Pharmacokinetics and Bioavailability of Cimetidine in Gastric and Duodenal Ulcer Patients , 1980, Clinical pharmacokinetics.

[28]  R. Branch,et al.  Further Observations on Relationships between Antipyrine Half-life, Clearance and Volume of Distribution: An Appraisal of Alternative Kinetic Parameters Used to Assess the Elimination of Antipyrine , 1980, Clinical pharmacokinetics.

[29]  D. Winship.  Cimetidine in the treatment of duodenal ulcer: review and commentary. , 1978, Gastroenterology.

[30]  W. C. Randolph,et al.  High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine. , 1977, Journal of pharmaceutical sciences.